Tirzepatide emerges a groundbreaking pharmaceutical agent for individuals battling type 2 diabetes. As a dual stimulator, it targets both read more the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) re… Read More